Suppressive ability of CD4+CD25+ Foxp3+ Treg cells isolated from PBMCs of CeD patients and controls has been investigated using autologous CD4+CD25- T responders (Tresp) cells, with conflicting results. The gene discussed is FOXP3; the disease is cranioectodermal dysplasia.